![COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England - The Lancet COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9e893b55-2210-44b7-90ac-4a593a981483/gr1_lrg.jpg)
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England - The Lancet
![Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.,Nature Medicine - X-MOL Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.,Nature Medicine - X-MOL](https://xpic.x-mol.com/20200410%2F10.1038_s41591-020-0800-0.png)
Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.,Nature Medicine - X-MOL
PLOS ONE: The Impact of Economic Crises on Communicable Disease Transmission and Control: A Systematic Review of the Evidence
![Uživatel Nature Medicine na Twitteru: „Toni Ribas @UCLA will next talk at #KSCancerImm about novel immune #checkpointblockade combos. He recently showed that treatment with anti-PD-1 or anti-PD-L1 agents produces a high response Uživatel Nature Medicine na Twitteru: „Toni Ribas @UCLA will next talk at #KSCancerImm about novel immune #checkpointblockade combos. He recently showed that treatment with anti-PD-1 or anti-PD-L1 agents produces a high response](https://pbs.twimg.com/media/D1jOzbXX4AEcBoM.png)
Uživatel Nature Medicine na Twitteru: „Toni Ribas @UCLA will next talk at #KSCancerImm about novel immune #checkpointblockade combos. He recently showed that treatment with anti-PD-1 or anti-PD-L1 agents produces a high response
![What a massive database of retracted papers reveals about science publishing's 'death penalty' | Science | AAAS What a massive database of retracted papers reveals about science publishing's 'death penalty' | Science | AAAS](https://www.sciencemag.org/sites/default/files/styles/article_main_large/public/Science53-color-1%20horizontal.jpg?itok=GQb_KAEe)
What a massive database of retracted papers reveals about science publishing's 'death penalty' | Science | AAAS
![IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma. - Nat. Med. - X-MOL IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma. - Nat. Med. - X-MOL](https://xpic.x-mol.com/20191206%2F10.1038_s41591-019-0671-4.png)
IMPRES does not reproducibly predict response to immune checkpoint blockade therapy in metastatic melanoma. - Nat. Med. - X-MOL
Women's knowledge: traditional medicine and nature; Mauritius, Reunion and Rodrigues - UNESCO Digital Library
![Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes | Nature Medicine Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-020-1008-z/MediaObjects/41591_2020_1008_Fig1_HTML.png)
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes | Nature Medicine
![Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease | Request PDF Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease | Request PDF](https://i1.rgstatic.net/publication/337095342_Glomerular_filtration_rate_by_differing_measures_albuminuria_and_prediction_of_cardiovascular_disease_mortality_and_end-stage_kidney_disease/links/5dc4f824299bf1a47b1fa576/largepreview.png)
Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease | Request PDF
![Nature Medicine در توییتر Nature Medicine در توییتر](https://pbs.twimg.com/media/EBTbxZDXkAAWLlV.jpg)
Nature Medicine در توییتر "First up from 2018: #Neoadjuvant combination treatment with nivolumab and ipilimumab in patients with high-risk #melanoma results in higher response rates than nivolumab monotherapy #NMEDClinical | https://t.co/QpHRjqbFdk ...
![How to Get Into Harvard Medical School: Requirements and Strategies — Shemmassian Academic Consulting How to Get Into Harvard Medical School: Requirements and Strategies — Shemmassian Academic Consulting](https://images.squarespace-cdn.com/content/v1/5269fbd3e4b0eb2b76ccc1db/1577751019290-EY3JVXDHNFFO753SL47M/ke17ZwdGBToddI8pDm48kG87Sfbgg29A4BYEDq3OXvgUqsxRUqqbr1mOJYKfIPR7LoDQ9mXPOjoJoqy81S2I8N_N4V1vUb5AoIIIbLZhVYxCRW4BPu10St3TBAUQYVKcf4OxbJOyh_wHUnyc4kQLQ6SBshRGOku7c30Y_IRDNPta8R2IY5BHMaEj1zOWoDTZ/How+To+Get+Into+Harvard+Medical+School+Shemmassian+Academic+Consulting.jpg)